Pancreatic Cancer Research

ResearcherNantong UniversityNo recent work listed

Erhao Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2654-6709; OpenAlex author ID A5084977515. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper

Papers 3

  1. The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression. Last author DOI 10.1186/s11658-021-00292-7↗
  2. Ubiquitin-specific protease 7 is a druggable target that is essential for pancreatic cancer growth and chemoresistance. Co-author DOI 10.1007/s10637-020-00951-0↗
  3. A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of TGFBR2. Co-author DOI 10.1016/j.cellsig.2019.109470↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yihui Fan · 2 shared papers, 2020 · strength 0.22
  2. Renfang Mao · 2 shared papers, 2020 · strength 0.22
  3. Xiaorong Zhou · 1 shared paper, 2021 · strength 0.13
  4. Weihan Li · 1 shared paper, 2021 · strength 0.13
  5. Hao Chen · 1 shared paper, 2020 · strength 0.11
  6. Guo-Xiong Zhou · 1 shared paper, 2020 · strength 0.11
  7. Xiaolin Zhu · 1 shared paper, 2020 · strength 0.10
  8. Guoxiong Zhou · 1 shared paper, 2020 · strength 0.10
  9. Jianbo Shen · 1 shared paper, 2020 · strength 0.10
  10. Mingbing Xiao · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.